Skip to main content
. 2015 Jun 9;113(1):69–75. doi: 10.1038/bjc.2015.187

Table 1. Summary of subject characteristics at diagnosis and p16/INK4A immunohistochemistry data (n=88).

  Male (n=72) Female (n=16) All (n=88)
Histology type, n (%)
Epithelioid 56 (77.8) 15 (93.7) 71 (80.7)
Biphasic 8 (11.1) 1 (6.3) 9 (10.2)
Sarcomatoid 8 (11.1) 0 (0) 8 (9.1)
Stages
T2 22 (30.6) 5 (31.2) 27 (30.7)
T3 40 (55.6) 5 (31.2) 45 (51.1)
T4 10 (13.8) 6 (37.5) 16 (18.2)
Chemotherapy, n (%)
Yes 51 (70.8) 13 (81.3) 64 (72.7)
No 21 (29.2) 3 (18.7) 24 (27.3)
p16 Expression
Negative/low 39 (54.2) 6 (37.5) 45 (51.1)
Intermediate 22 (30.5) 6 (37.5) 28 (31.8)
High 11 (15.3) 4 (25.0) 15 (17.1)

Values are expressed as n (%).